2026 MSK Cardio-Oncology Symposium

The rapid growth of cancer therapeutics has improved outcomes and survival for many patients while introducing new and significant cardiovascular risks—underscoring the importance of cardio-oncology at the critical intersection of cancer and heart health. This symposium will deliver a comprehensive, case-based curriculum that highlights the latest advances in cancer care alongside evidence-based strategies for the prevention, early detection, and management of cardiovascular disease in patients with cancer.

This year’s program features expert-led lectures, interactive case discussions, and a Thursday evening networking and poster session showcasing new research and emerging evidence shaping the future of the field. Designed for clinicians, researchers, and trainees, this symposium offers participants an opportunity to engage with cutting-edge science, exchange best practices, and build meaningful connections within the growing global cardio-oncology community.

Online Syllabus: Following the conclusion of the symposium, participants will receive one year of access to an online syllabus with recorded faculty presentations.

Target Audience: This program is intended for cardiologists, internists, hematologists/oncologists, advanced practice providers, nurses, and other allied healthcare professionals who care for patients with cancer or are interested in the evolving field of cardio-oncology.

Format and Location: This program will be held in person at the Zuckerman Research Center (417 East 68th Street, New York, NY). A virtual streaming option will be available to MSK employees only.

1. Describe contemporary anti-cancer therapies—including anthracyclines, targeted agents, immune checkpoint inhibitors, CAR-T and other cellular therapies, and hormonal therapies—highlighting their mechanisms of action and roles in cancer treatment.
2. Outline the cardiotoxicity profiles of these therapies and explain their impact on the cardiovascular system.
3. Apply principles of cardiovascular risk stratification based on patient- and treatment-specific factors to guide surveillance and management.
4. Determine strategies for monitoring and managing cardiotoxicity, recognizing both the supporting evidence and the current gaps in knowledge.
5. Explain diagnostic and therapeutic approaches to cardiac amyloidosis, including recent advances in disease-modifying treatments.
6. Demonstrate the principles of permissive cardiotoxicity and apply them to specific clinical scenarios.
7. Summarize the role and optimal use of cardiovascular imaging modalities in contemporary cardio-oncology, guided by current guidelines and best practices.
8. State the late cardiovascular sequelae of cancer treatment and outline best practices for managing the cardiovascular health of adult survivors of childhood and adolescent cancers.
9. Illustrate the unique challenges and strategies for managing acute cardiovascular disease in patients actively undergoing cancer therapy.

We are pleased to offer early discounted registration through March 19, 2026.

Early Registration Fees

• Physicians (MDs, PhDs, DOs): $500

• Advanced Practice Providers: $350

• Nurses: $300

• Residents, Fellows, and Trainees: $100*

• Industry Professionals: N/A (general rates apply) 

• MSK Employees: Complimentary**

General Registration Fees

• Physicians (MDs, PhDs, DOs): $600

• Advanced Practice Providers: $450

• Nurses: $400

• Residents, Fellows, and Trainees: $200

• Industry Professionals: $1,050***

• MSK Employees: Complimentary**

*Please note that any registration fee below the administrative cost—$100 for in-person registration—is non-refundable. View our cancellation policy below for details.
**MSK employees may attend the symposium in person or virtually via Zoom. If you register for in-person attendance, we kindly ask that you plan to participate on site. Should your availability change and you need to switch to virtual attendance, please email [email protected] so we can make the appropriate updates.
***An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our policy on Registration Discounts for more information.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credits™ and ABIM MOC points. 

We look forward to welcoming you to Memorial Sloan Kettering Cancer Center (MSK).

If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, MSK has negotiated special rates and amenities at select hotels in Manhattan. Click here to view the list of select hotels and additional details on each.

For details on planning your visit to MSK, including travel and parking information, click here. Please note that parking validation is not available for attendees.

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

MSK Symposium Directors 

Jennifer Liu, MD
Chief, Cardiology Service
Professor of Clinical Medicine, Weill Cornell Medical College

Anthony F. Yu, MD, MS
Associate Attending, Cardiology Service 
Associate Professor of Medicine, Weill Cornell Medical College 

Symposium Planning Committee 

Carol L. Chen, MD
Vice Chair, Quality Assurance
Attending, Cardiology Service
Memorial Sloan Kettering Cancer Center 

Stephanie Feldman, MD
Assistant Professor of Medicine, Division of Cardiology, Weill Cornell Medical College
Attending, New York Presbyterian-Weill Cornell Medical Center

Marie-Claude Beaulieu, MD
Cardio-oncology Fellow
Memorial Sloan Kettering Cancer Center 

Stephen Wisely, PA-C
Advanced Practice Provider 
Memorial Sloan Kettering Cancer Center 

Guest Faculty 

Daniel Addison, MD
Director of Translational Research, Division of Cardiology
Associate Professor of Internal Medicine
UT Southwestern Medical Center
Associate Director for Survivorship and Outcomes Research
Harold C. Simmons Comprehensive Cancer Center

Richard K. Cheng, MD, MSc
Professor of Cardiology
Section Head, Heart Failure, Mechanical Circulatory Support, Heart Transplant, and Cardio-Oncology
Program Director, Advanced Heart Failure and Transplant Cardiology
University of Washington Medical Center

Anita Deswal, MD, MPH, MBBS
Chair, Department of Cardiology
Ting Tsung and Wei Fong Chao Distinguished Chair
Professor of Medicine (Term-Tenure)
The University of Texas MD Anderson Cancer Center

Dmitriy N. Feldman, MD
Director, Endovascular Service
Interventional Cardiac and Endovascular Laboratory
NewYork-Presbyterian/Weill Cornell Medical Center

Michael G. Fradley, MD
Section Chief, Consultative Cardiology
Medical Director, Thalheimer Center for Cardio-Oncology
Associate Professor of Clinical Medicine (Cardiovascular Medicine)
Penn Medicine

Teresa López-Fernández, MD
Senior Consultant Cardiologist
La Paz University Hospital

Alexander Lyon, MA, BM, BCh, PhD
Consultant Cardiologist
Clinical Lead, Cardio-Oncology Service
Royal Brompton Hospital

Daniel Matthew McDonald, MD
Assistant Attending Physician
NewYork-Presbyterian Hospital
Assistant Professor of Medicine
Weill Cornell Medical College, Cornell University

Joshua D. Mitchell, MD
Associate Professor of Medicine
Director, Cardio-Oncology Center of Excellence
Director, Cardio-Oncology Fellowship
Co-Director, Amyloid Center of Excellence
Washington University School of Medicine

Anju Nohria, MD, MSc
Director, Cardio-Oncology Program
Dana-Farber Brigham Cancer Center
Cardiovascular Medicine Specialist
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School

Babak Navi, MD
Vice Chair, Neurology Hospital Services
Chief, Division of Stroke and Hospital Neurology
NewYork-Presbyterian Hospital
Medical Director, Weill Cornell Stroke Center
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Jayant K. Raikhelkar, MD
Assistant Professor of Medicine
Advanced Heart Failure and Cardiac Transplantation
Columbia University Irving Medical Center

Paaladinesh Thavendiranathan, MD, MSc
Professor of Medicine, Cardiology
Peter Munk Cardiac Centre, Toronto General Hospital
University Health Network
University of Toronto

Eric H. Yang, MD
Clinical Professor of Medicine
Ronald Reagan UCLA Medical Center

Jonathan W. Weinsaft, MD
Chief, Division of Cardiology
NewYork-Presbyterian Hospital
Professor of Medicine
Weill Cornell Medical College

MSK Faculty 

Karen A. Autio, MD, MSc
Assistant Attending, Genitourinary Oncology Service

Lior Z. Braunstein, MD
Associate Attending, External Beam Radiotherapy Service

Angel T. Chan, MD, PhD
Assistant Attending, Cardiology Service 

Chau T. Dang, MD
Attending, Breast Medicine Service 

Dipti Gupta, MD, MPH
Associate Attending, Cardiology Service 
Program Director, Cardio-Oncology Clinical Research Fellowship

Michelle N. Johnson, MD, MPH
Attending, Cardiology Service 
Vice Chair of Health Equity, Department of Medicine

Ioanna Kosmidou, MD
Associate Attending, Cardiology Service 

Heather J. Landau, MD
Director, Amyloidosis Program
Associate Attending, Bone Marrow Transplant Service 

Sarah Linhares, ACNP-BC, BSN, CHFN, DNP
Advanced Practice Provider 

Eileen P. McAleer, MD
Attending, Cardiology Service 

Miguel-Angel Perales, MD
Chief, Adult Bone Marrow Transplant Service

Jessica Scott, PhD
Head, Exercise Oncology Program and Principal Investigator

Brian Shaffer, MD
Associate Attending, Bone Marrow Transplant Service
Program Director, Bone Marrow Transplantation and Immunotherapy Fellowship Programs

Krishan Sharma, MD
Assistant Attending, Cardiology Service

James W. Smithy, MD, MHS
Assistant Attending, Melanoma Service 

Helena A. Yu, MD
Attending, Thoracic Oncology Service 

Jeffrey Zwicker, MD
Chief, Hematology Service

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.